Premature discontinuation of immunotherapy treatment before the recommended three-year period leads to incomplete therapy. In addition to failing to achieve the expected benefits, this situation can potentially cause more harm than good by increasing the patient's allergic sensitivity. Therefore, it is of great importance that the vaccine is administered for the full three-year duration.